MYCN and adrenal gland pheochromocytoma: Furthermore, MYCN‐amplified PCC was associated with a young age at onset, larger tumor size, and a higher risk of metastasis.[36, 37] To corroborate these observations, single‐cell data from four previously published PCC cases were integrated.[14] This analysis revealed that two PCC cases from the current study displayed a stronger alignment with the metabolic PCC subtype, known for its higher metastatic potential (Figure S7B,C, Supporting Information).